Middle East and Africa medication-assisted treatment is supportive and aims to reduce the severity of the symptoms. Data Bridge Market Research analyses that the medication-assisted treatment (MAT) market will grow at a CAGR of 7.1% from 2022 to 2029.
- The Middle East and Africa medication-assisted treatment market report offers one of the most excellent solutions to know the trends and opportunities in the Pharmaceutical industry.
- This market document has been mainly designed by keeping in mind the customer requirements which will ultimately assist in boosting return on investment (ROI).
- This market research study presents actionable market insights with which sustainable and money-spinning business strategies can be created.
- The report contains market-related analysis and estimation of various market related factors that are incredibly crucial for better decision making global research report comprises of an all-embracing research on the current conditions of the industry, the potential of the market in the present, and the future prospects from various angles.
- A transparent research method has been accomplished with the right tools and techniques to make the Middle East treatment market research report world-class. This report contains data on market definition, classifications, applications, engagements, market drivers, and market restraints all of which are obtained from SWOT analysis. In this report, a thorough investment analysis is offered which forecasts imminent opportunities for the market players and develops the strategies to grow return on investment (ROI).
- Information and data provided through the dominating blue Middle medication-assisted treatment market business report can be very decisive for the Pharmaceutical industry when it comes to dominate the market or create a mark in the market as a new emergent.
Get a sample of the report
Market Definition
Medication-assisted treatment (MAT) involves using medications, combined with counseling and behavioural therapies, to provide a complete patient approach to the treatment of substance use disorders. MAT is primarily used to treat addiction to opioids such as heroin and prescription pain relievers. For opioid overdose prevention medication, naloxone is used to prevent opioid overdose by reversing the toxic effects of the overdose. According to the World Health Organization (WHO) and Substance Abuse and Mental Health Services Administration (SAMHSA), naloxone is one of many medications considered essential to a functioning healthcare system.
In the Middle East and Africa, medication-assisted treatment is supportive and aims to reduce the severity of the symptoms. Data Bridge Market Research analyses that the medication-assisted treatment (MAT) market will grow at a CAGR of 7.1% from 2022 to 2029.
Middle East and Africa Medication-Assisted Treatment (MAT) Market Scope
The medication-assisted treatment (MAT) market is segmented on the basis of eight segments: type, products, drug type, dosage form, route of administration, population type, end user, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
Medication
Therapy
On the basis of type, the Middle East and Africa medication-assisted treatment (MAT) market are segmented into medication and therapy.
Products
Buprenorphine and Naloxone
Naltrexone
Buprenorphine
Methadone
Naloxone
Disulfiram
Acamprosate
On the basis of products, the Middle East and Africa medication-assisted treatment (MAT) market is segmented into buprenorphine and naloxone, naltrexone, buprenorphine, methadone, naloxone, disulfiram, and acamprosate.
Drug Type
Generics
Branded
On the basis of drug type, the Middle East and Africa medication-assisted treatment (MAT) market are segmented into generics and branded.
Dosage Form
Immediate Release
Extended Release
On the basis of dosage form, the Middle East and Africa medication-assisted treatment (MAT) market is segmented into immediate-release and extended-release.
Route of Administration
Oral
Parenteral
Others
On the basis of the route of administration, the Middle East and Africa medication-assisted treatment (MAT) market is segmented into oral, parenteral, and others.
Population Type
Adults
Teenage
On the basis of population type, the Middle East and Africa medication-assisted treatment (MAT) markets are segmented into adults and teenage.
End User
Rehabilitation Clinics
Hospitals
Specialty Centers
Homecare
Others
On the basis of end users, the Middle East and Africa medication-assisted treatment (MAT) market is segmented into rehabilitation clinics, hospitals, specialty centers, homecare, and others.
Distribution Channel
Hospital Pharmacy
Direct Tender
Retail Pharmacy
Online Pharmacy
Others
Medication-Assisted Treatment (MAT) Market Regional Analysis/Insights
The Middle East and Africa medication-assisted treatment (MAT) market are analyzed market size insights and trends are provided by regions, product type, type, application, workflow, end user, and distribution channel as referenced above.
The countries covered in the medication-assisted treatment (MAT) market report are South Africa, Saudi Arabia, the U.A.E, Egypt, Israel, Kuwait, and the Rest of the Middle East and Africa.
South Africa is expected to dominate the market due to a lack of awareness about substance use disorders and the rise in the population receiving medication-assisted treatment (MAT) and medication-assisted awareness programs medication-assisted treatment (MAT) in the Middle East and Africa region.
Competitive Landscape and Medication-Assisted Treatment (MAT) Market Share Analysis
- The Middle East and Africa medication-assisted treatment (MAT) market competitive landscape provide competitors' details. Components included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, the Middle East and Africa presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to the medication-assisted treatment (MAT) market.
- Some of the major players operating in the medication-assisted treatment (MAT) market are Indivior PLC, Sun Pharmaceutical Industries Ltd., Taj Pharmaceuticals Limited, Hikma Pharmaceuticals PLC, Pfizer Inc., Glenmark Pharmaceutical Inc., Viatris Inc., Alvogen, Accord Healthcare, Teva Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd.Amneal Pharmaceuticals LLC. among others.
Get Full Access to the Report
MAJOR TOC OF THE REPORT
Chapter One: Introduction
Chapter Two: Market Segmentation
Chapter Three: Market Overview
Chapter Four: Executive Summary
Chapter Five: Premium Insights
Chapter Six: Middle East and Africa Medication-Assisted Treatment (MAT) Market
Get TOC Details
Browse Related Reports@
https://www.databridgemarketresearch.com/reports/global-robotic-process-automation-market
https://www.databridgemarketresearch.com/reports/global-flavored-spirits-market
https://www.databridgemarketresearch.com/reports/global-rice-noodle-market
https://www.databridgemarketresearch.com/reports/global-antibiotics-market
https://www.databridgemarketresearch.com/reports/europe-food-container-and-kitchen-appliances-market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sopan.gedam@databridgemarketresearch.com